News

Snail venom holds key to better diabetes treatments

New research has found that venom extracted from a species of marine cone snail could hold the key to developing ‘ultra-fast-acting’ insulins, leading to more efficient therapies for diabetes management. Researchers from Australia and the US have successfully…

Global crowdsourcing contest to predict epileptic seizures begins

Some may remember that Kaggle actually had its origins in Australia but its founder moved soon after starting the company to Silicon Valley . He is an alumini of the Unviersity of Melbourne An online contest in association…

The deadly diseases scientists want to save

You’d think researchers who encounter some of the nastiest diseases affecting Australian animals would want to destroy them pronto. But that’s not the case for scientists involved with the country’s first Australian Wildlife Biobank, launched this week. These…

Zebrafish may hold key to antibiotic-resistant superbug infection fight

A chink in the armour of a deadly superbug has been revealed, providing scientists with a potential new pathway to annihilate the antibiotic-resistant infection. Using translucent zebrafish infected with glow-in-the-dark bacterial cells, Monash University scientists have been able…

Brainwave puts scientists step closer to building bionic brain

It’s been the stuff of science fiction since it was deemed theoretically possible in the 1970s but Sharath Sriram and his research team at RMIT have finally cracked it. They have built an artificial memory cell that could one day function…

2016 Eureka prize Winners

A number of BioMelbourne Network Members have won a Eureka Prize this year: CONGRATULATIONS Victorian winners include: Research & Innovation 2016 Scopus Eureka Prize for Excellence in International Scientific Collaboration WINNER FANTOM5, Harry Perkins Institute of Medical Research;…

Organ donation: Melbourne researchers identify way to prevent damage during transport

Melbourne researchers are preparing to change the way donated organs are transported, after identifying a protein that can prevent organ damage while en route to its recipient. This protein, called follistatin, will also soon be used by former…

Groundbreaking cancer discovery recognised by Eureka Prizes

The work that led to the development of a new anti-cancer drug has been awarded the Johnson & Johnson Eureka Prize for Innovation in Medical Research. Professor David Huang, Dr Peter Czabotar, Associate Professor Guillaume Lessene and Professor…

MyGolgi – Winners of the Innovation Showcase Scholarship

Melbourne-based health technology start-up company, MyGolgi, have won the 2016 Victorian State Government supported Innovation Showcase Scholarship. MyGolgi offer an easy-to-use wearable that provides consumers with continuous feedback for injury rehabilitation and prevention. The innovative device consists of…

Andrew Maxwell joins BioMelbourne Network Board

The BioMelbourne network is delighted to be able to announce that Andrew Maxwell is joining our Board of Directors as of this month. As the Managing Director of Chatsworth Associates, Andrew has worked with innovators, entrepreneurs and established…

Biotech drug scientist Dr Andrew Cuthbertson

Dr Andrew Cuthbertson has an awning of long, grey lashes above blue eyes. The lashes are unusual, thick and beautiful on a face that’s otherwise unremarkable. He’s been working since early morning. He’s watched the dawn break over parkland…

New advisory group launched to advance regenerative medicine

AusBiotech has formed the Regenerative Medicine Advisory Group, representing a new and rapidly-growing industry that is already delivering on the significant potential to provide vital health benefits worldwide.The Group will provide advice on current and emerging issues and…

Home

News & opinion

Member Directory

Events